Supplements · Sweeteners · Metabolic & Cardiometabolic
stevia decreases blood pressure
In plain terms: Does stevia lower blood pressure?
Part of: • Stevia
Only at doses far higher than you'd ever sweeten food with. The blood-pressure results come from giving hypertensive patients gram-level doses of stevioside - basically using it as a drug - and even those studies nearly all come from one research group. At normal tabletop amounts, stevia does nothing to blood pressure.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
The blood-pressure claim is **real but dose-dependent, and doesn't apply to everyday use**. The positive results come from older trials giving **gram-level pharmacological doses** of stevioside (750–1500 mg/day) to hypertensive patients — and nearly all of them trace to a **single, non-independent East-Asian research cluster**. Trials at ordinary tabletop/beverage doses find **no blood-pressure ef
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Hsieh MH et al. 2003 · Clin Ther | RCT | mixed | moderate | 2-yr RCT (174 mild hypertension): stevioside 1500 mg/d lowered SBP/DBP. [high dose; SAME research cluster as Chan - not independent] |
| Chan P et al. 2000 · Br J Clin Pharmacol | RCT | supports | moderate | 1-yr RCT (106 Chinese hypertensives): stevioside 750 mg/d lowered SBP/DBP vs placebo. [high pharmacological dose; single research cluster] |
| Jeppesen PB et al. 2003 · Metabolism | animal | supports | low | Diabetic rats: stevioside lowered systolic and diastolic BP - mechanism/plausibility, not human proof. |
| Ayoub-Charette S et al. 2025 · Am J Clin Nutr | meta-analysis | mixed | moderate | Bias-adjusted umbrella review (LNCS class): modest SBP reduction vs comparators at ordinary intake - NNS-class, not stevia-isolated. |
| Onakpoya IJ, Heneghan CJ 2015 · Eur J Prev Cardiol | meta-analysis | mixed | moderate | SR/meta: pooled BP reduction in hypertensives BUT flags high risk of bias, small trials, same research groups, dose-dependence. |
| Bundgaard Anker CC et al. 2019 · Nutrients | meta-analysis | mixed | moderate | SR/meta: BP effects inconsistent and dose-dependent; no robust benefit at typical consumption levels. |
| Barriocanal LA et al. 2008 · Regul Toxicol Pharmacol | RCT | contradicts | moderate | RCT at sweetener dose (250 mg TID): NO significant change in SBP/DBP in any group - 'apparent lack of pharmacological effect'. |
| Ferri LA et al. 2006 · Phytother Res | RCT | contradicts | moderate | RCT (mild hypertensives): crude stevioside up to 15 mg/kg/d showed NO antihypertensive effect beyond placebo (both fell). [moderate/culinary-comparable dose] |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.